Based on published research results: The higher the STK1 level, the lower the surviving rate and the worse
prognosis; and vice versa. Especially the multivariate COX regression analysis showed that the level of STK1
is an independent prognostic factor used for surviving rate and relapse risk assessment.
Progression-free survival curve (A) and overall survival curve (B) for patients treated with palliative chemotherapy, according? to decreased and increased levels of STK1 (n= 56).
Gastric carcinoma received palliative chemotherapy treatment: Developing changing relationship between
progression-free survival probability (A), overall survival probability (B) and low and high STK1 values (see
Liu YP,? et al., Changes in serum thymidine kinase 1 levels during chemotherapy correlate with objective response in
patientswith advanced gastric cancer. Exp Ther Med. 2011;2:1177-1181